RT Journal Article SR Electronic T1 THE METABOLIC FATE OF H3-CYCLAZOCINE IN DOGS JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 387 OP 396 VO 160 IS 2 A1 Mulé, S. J. A1 Clements, T. H. A1 Gorodetzky, C. W. YR 1968 UL http://jpet.aspetjournals.org/content/160/2/387.abstract AB The metabolism of H3-cyclazocine was studied in nontolerant, tolerant and abstinent dogs after a 1.25-mg/kg (free base) s. c. injection of the drug. Norcyclazocine and cyclazocine were identified in the urine of these dogs after extraction and direct application of hydrolyzed and unhydrolyzed urine samples to chromatographic paper buffered with 0.1 M phosphate or impregnated with silicic acid. The chromatograms were developed with tert.-amyl alcohol-n-butyl ether-water (80:7:13, v/v) or ethyl acetate-methanol-NH4OH (85:10:5, v/v). A method was developed for the estimation of H3-norcyclazocine in biologic material with a minimal sensitivity of 5 ng/ml. In the urine of nontolerant, tolerant and abstinent dogs, 2.3 to 2.7% of the H3-cyclazocine was recovered as free norcyclazocine and an equal amount as conjugated norcyclazocine. In the feces of these dogs, from 1.5 to 2.4% of the free and 0.02 to 0.7% of the conjugated norcyclazocine was obtained. Norcyclazocine was not found in the brain of the dogs at various time intervals, but the metabolite was obtained in peripheral tissues. Urine samples were subjected to acid and enzymatic hydrolysis, using β-glucuronidase and phenol sulfatase. The data indicated that the conjugate of both cyclazocine and norcyclazocine was a glucuronide. Norcyclazocine (1.0 mg/kg) did not significantly depress the flexor reflex of the chronic spinal dog. It is concluded that norcyclazocine is not an active metabolite of cyclazocine and that 47 to 66% of the administered H3-cyclazocine was accounted for as free and conjugated cyclazocine and norcyclazocine, as determined over a 5-day period. © 1968 by The Williams & Wilkins Company